PMCBHIGH SIGNALFINANCIAL10-K

PMCB reported extraordinary net income of $30.7M (up 9,085%) while simultaneously burning through 70% of its cash reserves and reducing share buybacks by 91%.

The massive swing from loss to profit appears driven by non-operating gains rather than business improvement, given operating losses only improved modestly and operating cash flow worsened. The dramatic decline in cash from $50M to $15M raises liquidity concerns despite the reported profitability.

Comparing 2025-08-11 vs 2024-08-13View on EDGAR →
FINANCIAL ANALYSIS

PMCB's financials show a contradictory pattern where net income surged 9,085% to $30.7M while cash declined sharply by 70% to $15.2M and operating cash flow worsened to -$3.0M. The company significantly reduced share buybacks from $28M to $2.5M and cut total liabilities by 84%, suggesting possible debt settlements or write-offs that may explain the profit spike. Overall, the financial picture suggests a one-time gain masking underlying operational challenges and deteriorating liquidity position.

FINANCIAL STATEMENT CHANGES
Net Income
P&L
+9085%
$334K$30.7M

Net income grew 9085% — bottom-line growth signals improving overall business health.

Share Buybacks
Cash Flow
-91%
$28.2M$2.5M

Buyback activity reduced 91% — capital being redeployed elsewhere or cash conservation underway.

Stockholders Equity
Balance Sheet
+87.7%
$27.6M$51.9M

Equity base grew 87.7% — retained earnings accumulation or equity issuance strengthening the balance sheet.

Total Liabilities
Balance Sheet
-83.9%
$20.4M$3.3M

Liabilities reduced 83.9% — deleveraging improves balance sheet strength and financial flexibility.

Cash & Equivalents
Balance Sheet
-69.8%
$50.2M$15.2M

Cash declined 69.8% — significant cash burn or deployment; verify adequacy of remaining liquidity runway.

Current Liabilities
Balance Sheet
-60.7%
$7.4M$2.9M

Current liabilities reduced — improved short-term financial position and working capital health.

Current Assets
Balance Sheet
-55.6%
$50.4M$22.4M

Current assets declined 55.6% — monitor working capital adequacy and short-term liquidity.

Operating Income
P&L
+48.6%
-$8.5M-$4.4M

Operating leverage kicking in — revenue growth outpacing cost growth, a hallmark of scaling businesses.

Operating Cash Flow
Cash Flow
-38.4%
-$2.2M-$3.0M

Operating cash flow fell 38.4% — earnings quality concerns; investigate working capital changes and non-cash items.

Accounts Receivable
Balance Sheet
+11.4%
$2K$3K

Receivables grew 11.4% — monitor days sales outstanding for collection efficiency.

LANGUAGE CHANGES
NEW — 2025-08-11
PRIOR — 2024-08-13
ADDED
As of August 4, 2025, the registrant had 6,795,779 outstanding shares of common stock.
In addition to reengaging SG Austria, we are also identifying alternative approaches to expand the prodrug/activator technology for cancer treatment.
This is a scalable technology that permits real-time analysis of long DNA fragments.
During the year ended April 30, 2025, our scientific consultants have been in active dialog with the FDA seeking permission to forego the large animal study.
The technology upon which the LAPC treatment will be based, intra-arterial chemotherapy, has been used in five clinical trials in humans.
+7 more — sign up free →
REMOVED
As of August 8, 2024, the registrant had 7,709,459 outstanding shares of common stock.
On August 15, 2022, we entered into a Cooperation Agreement (the Cooperation Agreement ) with Iroquois Master Fund Ltd.
and its affiliates, pursuant to which we elected a reconstituted board of directors (the Board ).
In addition to reengaging SG Austria, the Company is also identifying alternative approaches to expand the prodrug/activator technology for cancer treatment.
This is a cutting edge, unique and scalable technology that permits real-time analysis of long DNA fragments.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
PNRGHIGHPNRG achieved exceptional profitability improvement with net income surging 2,21...
2026-04-16
BNAIHIGHBNAI underwent a dramatic reverse stock split that reduced share count by 86% wh...
2026-04-16
LAKEHIGHLAKE's financial performance deteriorated significantly with operating losses wo...
2026-04-16
NXXTHIGHNextNRG experienced massive financial deterioration with operating losses explod...
2026-04-16
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →